Live Breaking News & Updates on Life Sciences Anavex

Stay updated with breaking news from Life sciences anavex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Anavex: Drug Treatments For Early Alzheimer's Disease (NASDAQ:AVXL)

Anavex 2-73/blarcamesine at high concentrations in early Alzheimer s disease leads to improvements in cognition. Click here to see our take on AVXL stock. ....

Alzheon Alz , Eli Lilly , Alzheimer Disease Cooperative Study , Anavex Life Sciences , Investment In Anavex Life Sciences , Autism Spectrum Disorders , Cellular Neuroscience , Life Sciences Anavex , Life Sciences , Disease Assessment Scale Cognitive , Mini Mental Examination Score , Disease Cooperative Study Activities , Daily Living , Clinical Dementia Rating Sum ,